# A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

> **NCT00002283** · NA · COMPLETED · sponsor: **Jacobus Pharmaceutical**

## Conditions studied

- Pneumonia, Pneumocystis Carinii
- HIV Infections

## Interventions

- **DRUG:** Trimethoprim
- **DRUG:** Sulfamethoxazole
- **DRUG:** Dapsone

## Key facts

- **NCT ID:** NCT00002283
- **Lead sponsor:** Jacobus Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002283, "A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00002283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*